Tectonic Therapeutic, Inc. (TECX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $23.93
• Market Cap: $432.53M
• EPS: $-2.69
• 52-Week High: $27.33
• 52-Week Low: $13.70

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. is an innovative biopharmaceutical company focused on the discovery and development of antibody-based therapies targeting G-protein-coupled receptors (GPCRs), which are crucial in a wide range of diseases. Headquartered in Watertown, Massachusetts, the company aims to address unmet medical needs by creating novel treatment options for patients who have not responded adequately to existing therapies. Through its cutting-edge research and development efforts, Tectonic...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tectonic Therapeutic, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TECX pay dividends?

Tectonic Therapeutic, Inc. (TECX) does not currently pay a regular dividend.

What is TECX's market cap?

Tectonic Therapeutic, Inc. (TECX) has a market capitalization of $432.53M with a current stock price of $23.93.